Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/W mice.
Previous work suggested that gonadal steroids influence immunity through the thymus, but the mechanisms were unclear. To investigate the effects of these hormones on immune responses to T1 and TD antigens in autoimmune mice, we studied hybrid NZB/W mice and the nonautoimmune DBA/2 strain. Mice castrated at 14 days of age were implanted with Silastic capsules releasing, in adults, physiologic levels of E2 in males or Te in females. Sham-operated controls received empty capsules. Splenic PFC were quantified 4 to 5 days after challenge with the TI2 antigen TNP-Ficoll, the TI1 antigen TNP-LPS, or the TD antigen SRBC. Young castrated NZB/W males implanted with E2 had striking enhancement of IgM responses to TNP-Ficoll when compared to castrated Te-treated females and comparable sham-operated controls of both sexes. E2 also stimulated responses to TNP-LPS. In response to challenge with SRBC, young E2-treated NZB/W males had a consistent trend to increased IgM PFC, and the stimulatory effect of E2 on IgG plaques was variable. Physiologic doses of Te had no consistent effect on responses in young mice. In old female NZB/W mice, Te caused PFC response after immunization with TNP-Ficoll to resemble age-matched NZB/W males. As sham-operated NZB/W females grew older, PFC responses to SRBC fell. This age-related phenomenon was delayed, however, in female castrates implanted with Te. In contrast, Te clearly suppressed responses to TNP-LPS. Implantation of E2 did not alter responses to TNP-Ficoll, TNP-LPS, or SRBC in nonautoimmune DBA/2 males. This finding suggested that exogenous E2 given in physiologic doses did not influence immunologic responsiveness in a normal strain to the degree seen in hormone-sensitive NZB/W mice. It was concluded that E2 enhanced responses to a variety of exogenous antigens in autoimmune NZB/W mice. The most consistent E2-induced increase in PFC response was observed with TI antigens, suggesting that E2 exerted its effects on B cells or Ts.
D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D000955:Antigens, T-Independent / Q000008:administration & dosage / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology*; D001402:B-Lymphocytes / Q000187:drug effects; D001789:Blood Group Antigens / Q000276:immunology; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005362:Ficoll / Q000031:analogs & derivatives / Q000276:immunology; D006462:Hemolytic Plaque Technique; D008070:Lipopolysaccharides / Q000276:immunology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D008814:Mice, Inbred NZB; D012756:Sheep / Q000276:immunology; D013739:Testosterone / Q000494:pharmacology*; D014301:Trinitrobenzenes / Q000276:immunology
D000955:Antigens, T-Independent; D001789:Blood Group Antigens; D008070:Lipopolysaccharides; C020529:TNP-ficoll; D014301:Trinitrobenzenes; D005362:Ficoll; D013739:Testosterone; D004958:Estradiol